Radiomedix

RadioMedix, Inc. is a clinical-stage biotechnology company headquartered in Houston, Texas, dedicated to developing innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and treatment of cancer. The company is advancing radiopharmaceuticals for PET imaging and therapeutic (alpha and beta-labeled) radiopharmaceuticals. RadioMedix has also established a 21 CFR 211-compliant contract service facility for academic and industrial partners: a full cGMP manufacturing and analytical suite for human clinical trials, as well as commercial-scale manufacturing of radiopharmaceuticals.